Tumor Microenvironment: Identifying Drivers of Progression and Resistance
2026-05-17 - 2026-05-20 | Whistler Conference Centre, 4010 Whistler Way, Whistler, BC (British Columbia), V8E 1J2, Canada
The Keystone Symposia conference, “Tumor Microenvironment: Identifying Drivers of Progression and Resistance,” will be held from May 17–20, 2026, at the Whistler Conference Centre in Whistler, British Columbia, Canada.
This conference will explore the complex interactions between tumor cells and their surrounding microenvironment, focusing on identifying the tumor-intrinsic and extrinsic signaling programs that drive cancer progression and influence systemic host responses, such as aging and immunity.
The meeting aims to highlight innovative experimental and computational tools to study the tumor microenvironment (TME), catalyze cross-disciplinary collaborations, and identify new therapeutic targets and methods for patient stratification.

IARC60 Conference: "Cancer Research into Action"
2026-05-19 - 2026-05-21 | Halle Tony Garnier, 20 Place Docteurs Charles et Christophe Mérieux, Lyon, Auvergne-Rhône-Alpes, 69007, France
The International Agency for Research on Cancer (IARC), part of the World Health Organization, will celebrate its 60th anniversary with the IARC60 Conference, themed “Cancer Research into Action.” The event will take place in Lyon, France, from 19 to 21 May 2026, bringing together leading scientists, researchers, policymakers, and public health professionals from around the globe.
This milestone conference will focus on how cutting-edge scientific discoveries can be effectively translated into tangible outcomes for cancer prevention and control. Discussions will center around three key themes: Discovery and Innovation for Cancer Prevention, Translating Research into Public Health Action, and the Science–Policy Interface for Global Change. Participants will have the opportunity to engage in multidisciplinary dialogue and contribute to shaping the future of global cancer research and policy.
The Call for Abstracts is now open, inviting researchers to submit their work and share insights that can advance cancer prevention worldwide. Further details about registration, including participation fees, are available on the official conference website.”
You can find more posts featuring IARC/WHO on OncoDaily.

ASCO 2026 Annual Meeting
2026-05-29 - 2026-06-02 | McCormick Place, 2301 S Martin Luther King Dr,, Chicago
The ASCO 2026 Annual Meeting is scheduled to take place from May 29 to June 2, 2026, at McCormick Place in Chicago. It is a major global oncology event organized by the American Society of Clinical Oncology, drawing over 40,000 oncology professionals worldwide.
The meeting will feature a comprehensive five-day program with more than 200 sessions that cover the latest advances in cancer research, treatments, and patient care. Both in-person and virtual attendance options will be available. The event offers opportunities for cutting-edge scientific presentations, expert insights, interactive education, and professional networking.

Tumor Metabolism: New Frontiers in Diet, Microbiome and Beyond
2026-06-08 - 2026-06-11 | INEC Killarney Convention Centre, Killarney Convention Centre, Muckross Road, Poulnamuck, Killarney, Co. Kerry (County Kerry), Ireland
The Keystone Symposia conference, “Tumor Metabolism: New Frontiers in Diet, Microbiome and Beyond,” is scheduled for June 8–11, 2026, and will be held at the INEC Killarney Convention Centre in Killarney, County Kerry, Ireland.
This meeting is designed to broaden the scope of cancer metabolism research by moving beyond tumor-intrinsic metabolism to explore the reciprocal relationship between cancer and whole-body (systemic) metabolism. The educational focus includes the critical roles of the microbiome, diet (including obesity, cachexia, and antioxidants), aging, and other metabolic diseases in controlling tumor development, aiming to generate novel insights and inspire cross-disciplinary collaborations for transformative treatment strategies.

EACR 2026 Congress: Innovative Cancer Science
2026-06-08 - 2026-06-11 | HUNGEXPO Budapest Congress and Exhibition Centre, Albertirsai út 10., Budapest, 1101, Hungary
The EACR 2026 Congress: Innovative Cancer Science is the Annual Congress of the European Association for Cancer Research (EACR).
This four-day congress, dedicated to basic, preclinical, and translational cancer research, will take place from June 8-11, 2026, in Budapest, Hungary. The congress is designed to showcase the latest research, highlight a wide breadth of topics, and bring together the cancer research community to inspire innovation and build knowledge, connections, and collaborations.
Sign up for the Congress email list.

64th Annual Conference of the Particle Therapy Cooperative Group (PTCOG 64)
2026-06-08 - 2026-06-13 | Centre International de Deauville, 1 Rue Lucien Barrière, Deauville, Normandy, 14800, France
The 64th Annual Conference of the Particle Therapy Cooperative Group (PTCOG 64) is a specialized international scientific meeting focused on the clinical, physical, and biological aspects of particle therapy for cancer treatment.
Scheduled for June 8–13, 2026, in Deauville, France, the conference includes an initial education program followed by a multi-day scientific program covering advancements in proton, carbon-ion, and other hadron therapies. Organized by the Particle Therapy Cooperative Group (PTCOG), the event serves as a technical platform for radiation oncologists, medical physicists, and researchers to discuss emerging technologies, treatment delivery precision, and multi-institutional clinical trial results.
Register.

The EHA Congress 2026
2026-06-11 08:00 - 2026-06-14 17:00 (America/Halifax) | Stockholm, Stockholm, Sweden
The EHA Congress 2026, set for June 11–14 in Stockholm, promises another outstanding scientific program that will bring together global leaders in hematology.
Attendees can expect high-impact sessions, including the Opening Ceremony, Plenary Abstracts Session, and Presidential Sessions—all designed to foster deep scientific engagement and share groundbreaking research.
In addition to the core plenary sessions, each day of the Congress will feature a range of expertly curated Sponsor Symposiums, offering further insights into innovative therapies, clinical advancements, and emerging technologies. EHA2026 will serve as a premier platform for collaboration, education, and shaping the future of hematology care worldwide.
More Posts Featuring EHA.

Advocates Webinar: Unlocking Next-Generation Therapies
2026-06-11 13:00 - 14:00 (America/Halifax)
The Advocates Webinar: Unlocking Next-Generation Therapies, hosted virtually by Friends of Cancer Research, is scheduled for Tuesday, June 11, 2026, from 1:00 PM to 2:00 PM ET.
The webinar is designed to follow up on the public meeting held in May, focusing specifically on translating complex discussions around cell and gene therapy development into clear, patient-focused takeaways for advocates. The session will highlight how modern regulatory approaches and innovative frameworks can accelerate patient access to safe and effective treatments.
Register.

ESMO Targeted Anticancer Therapies Asia Congress 2026
2026-06-12 - 2026-06-14 | Kerry Hotel, Hong Kong, 38 Hung Luen Road, Hung Hom Bay, Kowloon, China
The ESMO Targeted Anticancer Therapies Asia Congress 2026 will be a three-day event dedicated to advancing cancer drug discovery and precision oncology in the Asia-Pacific region.

Dates: June 12–14, 2026
Location: Kerry Hotel, Hong Kong SAR, China
Abstract Submission Deadline: March 31, 2026

This congress serves as a key platform for researchers, industry leaders, and clinicians to share the latest advances in early-phase drug development and targeted therapies.
Abstract Submission.

26th Workshop on Methods in Clinical Cancer Research
2026-06-13 - 2026-06-18 | De Ruwenberg Hotel, Ruwenbergstraat 7, Sint-Michielsgestel, 5271 AG, Netherlands
The 26th Workshop on Methods in Clinical Cancer Research (MCCR workshop) is a prestigious professional development event for oncology researchers, taking place from June 13–18, 2026, in Sint Michielsgestel, Netherlands.
Organized in collaboration by the European Organisation for Research and Treatment of Cancer (EORTC), the European Society for Medical Oncology (ESMO), and the American Association for Cancer Research (AACR), applications are currently open to participate in this highly-regarded course, which aims to provide comprehensive training on the design and conduct of successful clinical cancer research trials.
Apply.

The ESMO Gynaecological Cancers Congress 2026
2026-06-17 08:00 - 2026-06-19 17:00 (Europe/Copenhagen) | Bella Center, Center Boulevard 5, Copenhagen, 2300, Denmark
The ESMO Gynaecological Cancers Congress 2026 will take place from 17–19 June in Copenhagen, Denmark, as well as online.
This global event brings together experts, researchers, and healthcare professionals to explore the latest advancements in the diagnosis and treatment of ovarian, cervical, uterine, vaginal, and vulvar cancers. The programme features keynote lectures, interactive sessions, and dynamic discussions designed to promote collaboration and accelerate progress in gynaecological oncology.
With a strong emphasis on supporting young oncology professionals, the congress offers opportunities for early-career specialists to present their research, gain recognition, and connect with mentors. Scientific Co-Chairs Nicoletta Colombo, Kosei Hasegawa and Ana Oaknin from Barcelona lead the event, ensuring a comprehensive and impactful experience for all participants.
Read More Posts Featuring ESMO at OncoDaily.com.

MASCC/ISOO Annual Meeting 2026
2026-06-25 - 2026-06-27 | Melbourne Convention and Exhibition Centre (MCEC), 1 Convention Centre Pl, South Wharf, Victoria, 3006, Australia
The MASCC/ISOO Annual Meeting 2026 is the premier international event dedicated to supportive cancer care, hosted jointly by the Multinational Association of Supportive Care in Cancer (MASCC) and the International Society of Oral Oncology (ISOO). The meeting is scheduled to take place from June 25 – 27, 2026, in the vibrant city of Melbourne, Australia. This annual gathering serves as a key platform for interdisciplinary collaboration, networking, and presenting cutting-edge research to a global audience of specialists.
The overall theme for the 2026 meeting is “Coordinated and Individualized Supportive Cancer Care,” with key topics including: “Mind the Gap”: Maximizing Access to Supportive Care for All, Lifestyle and Behavioral Support in Cancer Care, and Optimizing Toxicity Management of Novel Therapies. In addition to a comprehensive scientific program covering the full spectrum of supportive care topics, the event will feature social opportunities to showcase Melbourne’s renowned food, arts, and sports scenes, aiming to be both enriching and memorable for all attendees.
You can find more posts featuring MASCC on OncoDaily.

ASCO Breakthrough 2026
2026-06-25 08:00 - 2026-06-27 17:00 (America/Halifax) | Raffles City Convention Centre, Raffles City Convention Centre, 80 Bras Basah Road Singapore, Singapore
ASCO Breakthrough 2026 will take place from 25–27 June 2026 in Singapore at the Raffles City Convention Centre, bringing together global oncology experts to share cutting-edge research and practical insights.
This event offers a unique platform for multidisciplinary education, case-based discussions, and rapid research presentations designed to highlight the latest developments in cancer care.
The programme includes keynote lectures from international leaders, daily rapid oral abstract and poster sessions, expert-led Poster Walks, and structured networking opportunities. ASCO Breakthrough continues its focus on fostering collaboration and advancing innovation in oncology, with a particular emphasis on real-world application and global knowledge exchange.
Further Reading: ASCO Breakthrough 2025.

21st MRS Biennial Congress
2026-06-28 - 2026-07-01 | Salt Lake City Marriott Downtown at City Creek, 75 S W Temple St, Salt Lake City, UT 84101, USA, Salt Lake City, UT, 84101, United States
The 21st MRS Biennial Congress is a specialized scientific meeting organized by the Metastasis Research Society (MRS) to discuss the latest advancements in the study of cancer metastasis.
Scheduled for June 28-July 1, 2026, in Salt Lake City, Utah, the congress focuses on the molecular mechanisms of cancer spread, the role of the tumor microenvironment, and the development of new anti-metastatic therapies. The program brings together basic researchers, clinical oncologists, and industry experts to address the technical challenges of treating advanced disease and to foster international collaboration in metastatic research.

The ESMO Gastrointestinal Cancers Congress 2026
2026-07-01 00:00 - 2026-07-04 00:00 (America/Halifax) | Munich, Germany, Munich, Germany
The ESMO Gastrointestinal Cancers Congress 2026 will be held from 1 to 4 July in Munich, Germany, and online.
This major event brings together global experts, researchers, and healthcare professionals focused on improving prevention, diagnosis, and treatment across the full spectrum of gastrointestinal cancers.
With a programme featuring expert-led discussions, tumour boards, clinical debates, and presentations of the latest research, participants will gain practical insights and updates on GI oncology. The congress is designed to promote collaboration and knowledge exchange, offering opportunities to engage with peers and help shape the future of gastrointestinal cancer care.
Read More Posts Featuring ESMO at OncoDaily.com.

Cancer Research UK's Inaugural Pancreatic Cancer Conference 2026
2026-07-07 - 2026-07-09 | Park Plaza Victoria London, 239 Vauxhall Bridge Road, London, Greater London (England), SW1V 1EQ, United Kingdom
The Cancer Research UK’s Inaugural Pancreatic Cancer Conference 2026 is a three-day scientific event focused on advancing research into pancreatic ductal adenocarcinoma (PDAC), running from Tuesday, July 7, to Thursday, July 9, 2026.
The conference, which includes networking, poster sessions, and keynote addresses from experts like Christine Iacobuzio-Donohue, will feature sessions exploring critical topics such as the role of the exposome, tumour heterogeneity, malignant-stromal cell evolution, and innovative technologies for early detection and interception.
It is organized by a scientific committee composed of leading researchers like Anirban Maitra and Dieter Saur, with the goal of fostering collaboration and highlighting cutting-edge solutions for this cancer of unmet need.

5th Sapporo Conference for Palliative and Supportive Care in Cancer
2026-07-10 - 2026-07-11 | Sapporo Park Hotel, 3-chōme-1-1 Minami 10 Jōnishi, Chuo Ward, Sapporo, Hokkaido, 064-8589, Japan
The 5th Sapporo Conference for Palliative and Supportive Care in Cancer (SCPSC), organized by the International Research Society of the Sapporo Conference for Palliative and Supportive Care in Cancer, is scheduled for July 10th to 11th, 2026.
This two-day conference will be held at the Sapporo Park Hotel in Japan, with Masayoshi Kobune from Sapporo Medical University serving as the Chair. The event is a key platform for advancing research and clinical practice in supportive cancer care.

APPOS Austin 2026
2026-07-17 - 2026-07-18 | Sheraton Austin Georgetown Hotel & Conference Center, 1101 Woodlawn Ave, Georgetown, TX, 78628, United States
The APPOS Austin 2026 (Advanced Practice Providers Oncology Summit) is a two-day continuing medical education conference scheduled for July 17–18, 2026, at the Sheraton Austin Georgetown Hotel and Conference Center.
Organized by Horizon CME, the summit is designed to provide advanced practice providers (APPs), including NPs, PAs, pharmacists, and nurses, with the latest evidence-based strategies to optimize care and outcomes for patients with cancer. The event offers a unique platform for APPs and other oncology clinicians to collaborate, learn from national faculty, and share best practices on various issues related to the care of cancer patients.

ESMO Course in Medical Oncology for Medical Students 2026
2026-07-24 - 2026-07-28 | INCLIVA Biomedical Research Institute, C. de Menéndez y Pelayo, 4, Valencia, 46010, Spain
The ESMO Course in Medical Oncology for Medical Students 2026 is an interactive, four-day residential educational program taking place from July 24 to 28, 2026, in Valencia, Spain. Organized by the European Society for Medical Oncology (ESMO), the course is specifically designed for fourth and fifth-year medical students. Co-Chaired by Andrés Cervantes and Rodrigo Sanchez Bayona (Spain), the course provides a high-standard, interactive educational program—including state-of-the-art lectures, clinical case discussions, and dedicated workshops—with the primary goal of providing insight into the field of medical oncology and motivating students to commit to this fast-evolving specialty.

OPN New Jersey - New York Chapter Conference 2026
2026-08-01 | New York Marriott Marquis, 1535 Broadway, New York, NY, 10036, United States
The 2026 OPN New Jersey – New York Chapter Conference is a regional oncology pharmacy summit scheduled for August 1, 2026, at the New York Marriott Marquis in New York City.
Hosted by the Oncology Pharmacy Network (OPN) and Horizon CME, this collaborative event brings together hematology/oncology pharmacy clinicians – including pharmacists and pharmacy technicians – to network and discuss emerging agents, updated clinical guidelines, and strategies for optimizing patient care.
Register.

7th Global Cancer Summit (GCS 2026)
2026-08-23 | Swatantrata Bhawan Auditorium, Banaras Hindu University (BHU), Lanka, BHU Campus, Varanasi, Uttar Pradesh, 221005, India
The 7th Global Cancer Summit (GCS 2026), themed “Living with Cancer in the 21st Century,” is scheduled for August 23, 2026, at the Swatantrata Bhawan Auditorium, Banaras Hindu University (BHU) in Varanasi, Uttar Pradesh, India.
Organized by the BioGenesis Health Cluster and the Global Cancer Foundation, this summit focuses on the global burden of cancer, with a special emphasis on women’s cancers. The scientific program aims to bring together international experts through plenary sessions, live workshops on topics like breast and cervical cancer, and interactive discussions to devise strategies against the disease.
Register.

Molecular Analysis for Precision Oncology Congress 2026
2026-09-10 - 2026-09-11 | London, United Kingdom
The Molecular Analysis for Precision Oncology (MAP) Congress 2026, co-organized by the European Society for Medical Oncology (ESMO), Cancer Research UK (CRUK), and Unicancer, is scheduled for 10–11 September 2026 in London, United Kingdom.
This high-level, two-day meeting will serve as a platform for experts in oncology, molecular diagnostics, and precision medicine to converge and exchange ideas.
The primary focus of the congress is to share advances in cancer research, strengthen interdisciplinary connections, and accelerate the translation of molecular insights – particularly concerning molecular profiling, biomarker discovery, and personalized treatment strategies – into routine clinical practice to improve global patient care.

World Conference on Lung Cancer 2026
2026-09-12 00:00 - 2026-09-15 00:00 (Asia/Seoul) | Seoul, South Korea, Seoul, 01000
IASLC 2026 World Conference on Lung Cancer (WCLC), will be held from September 12-15, 2026, in Seoul, South Korea.
The International Association for the Study of Lung Cancer (IASLC) is pleased to announce that it is now accepting applications from qualified IASLC member groups in Asia and the Rest of the World to serve as Co-Chairs.7 for this event.
The WCLC delivers an exciting and practice changing program with wide-ranging and multidisciplinary content. In addition to traditional abstract presentations and lectures by world-renowned invited speakers, WCLC offers interactive sessions, hands on workshops as well as several sessions specifically dedicated to nurses, patients, and advocates.
Find more information about IASLC at OncoDaily.com.

OPN California North Chapter Conference 2026
2026-09-19 | Hilton San Francisco Airport Bayfront, 600 Airport Blvd, Burlingame, CA, 94010, United States
The 2026 OPN California North Chapter Conference is a one-day regional summit tailored for hematology and oncology pharmacy clinicians, including pharmacists and pharmacy technicians.
Organized by the Oncology Pharmacy Network (OPN) in collaboration with Horizon CME, the conference focuses on the latest evidence-based strategies in cancer care and provides a platform for professional networking and collaboration. The event is part of a series of regional meetings aimed at optimizing patient outcomes through advanced pharmaceutical insights.

ACORD Workshop 2026
2026-09-20 - 2026-09-25 | Novotel Sydney Olympic Park, 11A Olympic Blvd, Sydney Olympic Park, NSW (New South Wales), 2127, Australia
The Australia and Asia Pacific Clinical Oncology Research Development (ACORD) Workshop 2026, presented by the Medical Oncology Group of Australia (MOGA), is a prestigious six-day residential program dedicated to advancing clinical cancer research across the Asia-Pacific region.
Scheduled to take place from September 20-25, 2026, at the Novotel Sydney Olympic Park in NSW, Australia, the workshop is designed for early-career clinical cancer researchers – including medical, surgical, radiation oncology, palliative care, and allied health professionals – who are near the end of their training or within five years post-specialization.
Participants are selected through a competitive process based on the quality and feasibility of a proposed research concept, and the program focuses on intensive protocol development group sessions, one-to-one faculty mentorship, and lectures by leading local and international experts.

EACR Liquid Biopsies 2026
2026-09-22 - 2026-09-24 | L’Ecole Normale Supérieure de Lyon, 15 parvis René Descartes, Lyon, Auvergne-Rhône-Alpes, 69342, France
The European Association for Cancer Research (EACR) conference, “Liquid Biopsies 2026,” will take place in Lyon, France, from September 22–24, 2026. This conference will gather world-leading experts to explore the latest advances in circulating nucleic acids, circulating tumour cells (CTCs), and extracellular vesicles (EVs) across the entire cancer continuum.
The educational program is structured into four focused sessions – Localised Cancers, Metastatic Cancers, Technology, and Biology – to bridge technological innovation (including fragmentomics and spatial transcriptomics) with biological insights and clinical translation, ultimately aiming to accelerate the integration of liquid biopsy approaches into cancer care for improved patient outcomes.
Register.

The 25th International Cancer Imaging Society Meeting and Annual Teaching Course
2026-09-23 - 2026-09-25 | Europa Hotel, Great Victoria St, Belfast, Northern Ireland, BT2 7AP, United Kingdom
The 25th International Cancer Imaging Society Meeting and Annual Teaching Course (ICIS 2026) is an in-person event scheduled for September 23–25, 2026, starting at 7:45 AM, at The Europa Hotel in Belfast, Northern Ireland.
Co-hosted with the Faculty of Radiologists and Radiation Oncologists of the Royal College of Surgeons in Ireland (RCSI), the conference theme is “Fundamentals of Imaging Cancer with Automated Assistance,” aiming to reaffirm core cancer imaging principles while highlighting the growing role of automated and AI-driven techniques in clinical practice.
The program will feature keynote lectures, plenary sessions, hands-on workshops, and scientific presentations, all intended to improve participants’ understanding of precision imaging, advanced interventions, and clinical reporting skills.

World Cancer Congress 2026
2026-09-24 - 2026-09-26
The World Cancer Congress 2026 will be held from September 24 to 26, 2026, in Hong Kong, organized by the Union for International Cancer Control (UICC) in collaboration with the Hong Kong Anti-Cancer Society. This biennial event attracts thousands of participants from over 130 countries, including global cancer experts, policymakers, researchers, and advocates.
It focuses on advancing cancer control through knowledge exchange, innovative research, prevention, treatment, and policy discussions. World Cancer Congress 2026 will feature plenary sessions, workshops, and networking opportunities aimed at fostering collaboration and transformative progress in cancer care and prevention worldwide. Hong Kong’s advanced healthcare facilities and strategic location make it an ideal host for this significant global cancer event

ASTRO Annual Meeting 2026
2026-09-26 - 2026-09-30 | Boston Convention and Exhibition Center, 415 Summer Street, Boston, MA, 02210, United States
The 68th ASTRO Annual Meeting of the American Society for Radiation Oncology will be held from September 26 to September 30, 2026, in Boston, Massachusetts, with both in-person and on-demand options. This event is the premier gathering for the global radiation oncology community, serving as the central platform for discussing the latest advances in radiation therapy research, clinical practice, and technology. It attracts oncologists, physicists, biologists, and other healthcare professionals who focus on improving cancer treatment through targeted radiation delivery.
Key preparatory dates for the event include the opening of the Call for Education Sessions on November 6, 2025, and the opening of the Call for Abstracts on December 2, 2025. These submissions are crucial in shaping the scientific and educational program, ensuring the event highlights the most innovative research and clinical trials set to impact patient care and future practice guidelines in the field of radiation oncology.
You can find more posts featuring ASTRO on OncoDaily.

EACR Conference on Cancer Metabolism
2026-10-06 - 2026-10-08 | The Euskalduna Conference Centre, Abandoibarra Etorb., 4, Abando, Bilbao, Bizkaia, 48011, Spain
The European Association for Cancer Research (EACR) Conference on Cancer Metabolism will be held in Bilbao, Spain, from October 6–8, 2026. This conference focuses on metabolic reprogramming, a key hallmark of tumors, and the metabolic alterations that cancer and stromal cells undergo to meet energetic demands, survive in hostile environments, and modify their niche.
The meeting will gather top experts to discuss the mechanisms through which metabolites regulate cell decisions, the metabolic interaction between the tumor and the host, and explore undocumented metabolic alterations in cancer. It targets basic and translational scientists and clinicians, aiming to provide a broad and detailed overview of the most recent advances in the field.
Register.
